Invesco NASDAQ Biotech UCITS ETF (SWX:SBIO)

Switzerland · Delayed Price · Currency is CHF · Price in USD

74.93

+1.52 (2.07%)

Last updated: Sep 22, 2026, 4:39 PM CET

Assets	486.89M
Expense Ratio	n/a
PE Ratio	n/a
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	+49.50%

Volume	15,944
Open	73.40
Previous Close	73.41
Day's Range	73.37 - 74.93
52-Week Low	49.00
52-Week High	77.11
Beta	n/a
Holdings	n/a
Inception Date	Nov 6, 2014

About SBIO

Invesco NASDAQ Biotech UCITS ETF is an exchange traded fund launched by Source Investment Management Limited. The fund is managed by Assenagon Asset Management S.A. It invests in the public equity markets across the globe. The fund uses derivatives such as swaps to invest in the stocks of companies operating in the biotechnology and pharmaceuticals sectors. It invests in the stocks of companies across all market capitalizations, with a minimum market capitalization of US $200 million. The fund seeks to replicate the performance of the NASDAQ Biotechnology Index, by employing synthetic replication methodology. Invesco NASDAQ Biotech UCITS ETF was formed on November 6, 2014 and is domiciled in Ireland.

Category Sector Equity Biotechnology

Stock Exchange SIX Swiss Exchange

Ticker Symbol SBIO

Performance

SBIO had a total return of 49.50% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.59%.